Envista (NYSE:NVST – Get Free Report) was upgraded by Leerink Partnrs from a “strong sell” rating to a “hold” rating in a note issued to investors on Thursday, Zacks.com reports. Leerink Partnrs also issued estimates for Envista’s FY2024 earnings at $0.70 EPS, Q1 2025 earnings at $0.22 EPS, Q2 2025 earnings at $0.22 EPS, Q3 2025 earnings at $0.30 EPS, Q4 2025 earnings at $0.32 EPS and FY2026 earnings at $1.28 EPS.
NVST has been the topic of several other research reports. Evercore ISI raised their price target on shares of Envista from $18.00 to $23.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. JPMorgan Chase & Co. downgraded shares of Envista from an “overweight” rating to a “neutral” rating and reduced their price target for the stock from $23.00 to $16.00 in a research note on Thursday, August 8th. Wells Fargo & Company started coverage on shares of Envista in a report on Tuesday, October 8th. They set an “equal weight” rating and a $20.00 target price on the stock. Bank of America dropped their target price on shares of Envista from $22.00 to $19.00 and set a “buy” rating on the stock in a report on Thursday, August 8th. Finally, Leerink Partners upgraded shares of Envista from an “underperform” rating to a “market perform” rating and increased their target price for the stock from $16.00 to $23.00 in a report on Thursday. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $20.71.
Read Our Latest Stock Report on NVST
Envista Trading Down 0.1 %
Envista (NYSE:NVST – Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.12 EPS for the quarter, topping the consensus estimate of $0.09 by $0.03. The company had revenue of $601.00 million for the quarter, compared to the consensus estimate of $590.34 million. Envista had a negative net margin of 53.42% and a positive return on equity of 3.59%. The firm’s revenue was down 4.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.43 EPS. As a group, analysts expect that Envista will post 0.69 EPS for the current year.
Insider Activity
In related news, CFO Eric D. Hammes acquired 24,532 shares of the firm’s stock in a transaction that occurred on Monday, August 12th. The stock was purchased at an average cost of $16.33 per share, with a total value of $400,607.56. Following the transaction, the chief financial officer now directly owns 24,532 shares of the company’s stock, valued at $400,607.56. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 1.30% of the company’s stock.
Hedge Funds Weigh In On Envista
Several hedge funds and other institutional investors have recently modified their holdings of the stock. State of Michigan Retirement System raised its position in Envista by 2.4% during the 1st quarter. State of Michigan Retirement System now owns 42,163 shares of the company’s stock worth $901,000 after buying an additional 1,000 shares during the last quarter. Capstone Investment Advisors LLC raised its position in Envista by 51.3% during the 1st quarter. Capstone Investment Advisors LLC now owns 64,779 shares of the company’s stock worth $1,385,000 after buying an additional 21,950 shares during the last quarter. FORA Capital LLC raised its position in Envista by 11.1% during the 1st quarter. FORA Capital LLC now owns 52,198 shares of the company’s stock worth $1,116,000 after buying an additional 5,205 shares during the last quarter. Mutual of America Capital Management LLC raised its position in Envista by 1.0% during the 1st quarter. Mutual of America Capital Management LLC now owns 196,022 shares of the company’s stock worth $4,191,000 after buying an additional 1,967 shares during the last quarter. Finally, Central Pacific Bank Trust Division purchased a new position in shares of Envista during the 1st quarter valued at approximately $479,000.
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Recommended Stories
- Five stocks we like better than Envista
- The How and Why of Investing in Gold Stocks
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.